Bioweapons — Synthetic Biology, BTWC, India’s Biosecurity (UPSC Science & Tech)

A pandemic can kill more people than a nuclear exchange without a single warhead being launched. COVID-19's 7 million deaths reshaped how governments think about biological threats — whether natural, accidental or deliberate. Unlike nuclear weapons, which are traceable and require vast infrastructure, engineered pathogens can be produced in a small laboratory. The Biological and Toxin Weapons Convention (BTWC) 1972 bans them — but without verification, without inspections, and without an enforcement body.

For UPSC GS III, bioweapons link science and technology, defence, international relations and governance under a theme that has become impossible to ignore after 2020.

Synthetic Biology — The Double-Edged Sword

Synthetic biology engineers organisms at the genetic level for useful purposes — biofuels, vaccines, cell therapies. The same techniques can be used to:

• Enhance the virulence of pathogens.
• Bypass vaccine immunity.
• Target ethnic groups via genetic profiling.
• Create new toxins.

CRISPR-Cas9, AI-driven protein design, AlphaFold, DNA synthesis services have lowered the technical barrier for sophisticated biological manipulation.

Threats

• State bioweapons programmes — Historically pursued by US, USSR, UK, Japan and others; believed inactive but never fully verified.
• Non-state actors and terrorist groups — Aum Shinrikyo attempted anthrax; Amerithrax attacks 2001.
• Accidental laboratory leaks — COVID-19 debate.
• Gain-of-function research risks.
• Dual-use research of concern (DURC) — Legitimate research that could be misused.
• Biohacker movement — Low-cost CRISPR kits for amateurs.

Biological and Toxin Weapons Convention (BTWC) 1972

The BTWC was the first multilateral disarmament treaty banning an entire category of weapons. Key terms:

• Prohibits development, production, stockpiling, acquisition, retention and transfer of biological agents and toxins that have no peaceful justification.
• Requires destruction or diversion to peaceful purposes within 9 months of entry into force.
• Indefinite duration.
• Allows UN Security Council complaint mechanism — never used.
• 187 states parties as of 2024.
• India ratified the BTWC in 1974.

Gaps in the BTWC Regime

Universality Gap

• Several states have not ratified (Israel, Egypt, etc.).
• Does not bind non-state actors directly.

Implementation Gap

• No verification mechanism — Unlike the Chemical Weapons Convention (CWC), the BTWC has no OPCW-equivalent inspection body.
• National-level enforcement varies.

Response Gap

• Silent on how states should respond to a biological attack.
• UNSC complaint can be vetoed.

Institutional Gap

• Meetings infrequent.
• Implementation Support Unit (ISU) since 2007 has limited mandate and funding.

Strengthening Proposals

• Extend OPCW's mandate to cover biological weapons.
• Revive the Verification Protocol (negotiations collapsed 2001 when US withdrew).
• Encourage universal ratification.
• Establish a permanent secretariat.
• Integrate with WHO and One Health governance.
• Address dual-use research of concern.

India's Biosecurity Preparedness

Strengths

• Strong vaccine manufacturing — Serum Institute, Bharat Biotech.
• INSACOG — COVID-era genome surveillance.
• National Centre for Disease Control (NCDC), Delhi — IDSP (Integrated Disease Surveillance Programme).
• DRDE Gwalior — DRDO's lead biodefence lab.
• ICMR labs — High-containment BSL-3 and BSL-4 facilities.
• Disaster Management Act 2005 — Enables national response.
• Epidemic Diseases Act 1897 (colonial vintage; reformed 2020).

Weaknesses

• Coordination gaps — Multiple ministries (Health, Agriculture, Science, Environment, Defence) with limited integration.
• No dedicated biosecurity law.
• Porous borders allow pathogen entry.
• Limited BSL-4 capacity — Only one active BSL-4 lab.
• Genomic surveillance gaps for endemic pathogens.
• Zoonotic surveillance weak under One Health.
• Disease reporting delays at district level.
• Weak public-private-military integration.

Institutional Reforms Needed

• National Biosecurity Authority to consolidate oversight.
• Biosafety and biosecurity regulation aligned with international best practice.
• One Health approach linking human, animal, environmental surveillance.
• Pandemic preparedness fund and pre-negotiated vaccine capacity.
• Border biosurveillance at airports, seaports, land crossings.
• Training — Epidemiologists, virologists, biosafety officers.
• Bioethics framework for dual-use research.

India's Role in BTWC

• Supports universalisation and a verification protocol.
• Opposes weaponisation while asserting right to peaceful biotechnology.
• Hosts bioscience cooperation programmes.
• India is a signatory to WHO's International Health Regulations (2005).

Related Policy Initiatives

• National Biotechnology Development Strategy (2021-25) — BioE3 successor.
• BioE3 Policy (August 2024) — Includes biosafety and biosecurity as enablers.
• National Policy on Biofuels.
• Biomedical Waste Management Rules.
• Biological Diversity Act 2002 and 2023 amendment.

Latest Developments (2024-26)

• Pandemic Treaty (WHO) — Under negotiation through 2024-26.
• WHO IHR amendments 2024 — Strengthen pandemic reporting.
• INSACOG model being extended to TB, dengue, avian influenza.
• BioE3 Policy (August 2024) — Frames biosecurity as national priority.
• India Semiconductor Mission — PCR and sequencing chipsets on DLI priority list.
• National Quantum Mission (2023) — Quantum biosensors for pathogen detection.
• AI policy (IndiaAI Mission, 2024) — AI for outbreak prediction and drug discovery.
• DPDP Act 2023 — Health data and disease surveillance data under data-fiduciary rules.
• Chandrayaan-4 and Gaganyaan — Space microbiome and biosafety research.
• iCET partnership (US-India 2024) — Biotechnology cooperation including biosecurity.
• BSL-4 expansion — New high-containment lab planned at NIV Pune.
• One Health Mission (2023) — Coordinated human-animal-environment surveillance.

UPSC Relevance

Prelims angles

• BTWC — 1972, entered into force 1975; India ratified 1974.
• 187 states parties.
• No verification mechanism.
• Implementation Support Unit (ISU) — 2007.
• OPCW — for chemical weapons (CWC).
• NCDC, ICMR, DRDE Gwalior, INSACOG.
• Dual-use research of concern (DURC).

Mains angles

• GS III — Defence: "Synthetic biology as a strategic threat — Indian preparedness."
• GS II — International relations: "Evaluate BTWC and the case for reform."
• GS III — Governance: "Biosecurity architecture in India needs consolidation. Discuss."

Essay angles

• "Invisible warfare — pathogens as weapons."
• "From pandemic to preparedness — India after COVID."

Practice question — "COVID-19 exposed critical biosecurity gaps in India. Propose reforms in institutions, law and international cooperation."

Biology is the new frontier of both medicine and warfare. A country that masters the medical side but ignores the warfare side is a country waiting for its next crisis. India's biosecurity agenda after 2024 needs to be as ambitious as its biopharma — with dedicated institutions, new laws and serious money.